According to a recent LinkedIn post from Resilience Care, U.S. advisory board member Eddie Martucci participated in a panel at the International Society of Geriatric Oncology (SIOG). The discussion reportedly focused on how to better support older cancer patients, a group described as underrepresented in research and innovation.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post indicates that, as part of the CARG masterclass, the panel examined ways to increase the inclusion of older adults in clinical trials, noting this as a key industry challenge. As shared in the post, the conversation also covered real‑world use of remote patient monitoring and electronic patient‑reported outcomes (ePROs) to improve continuous follow‑up, symptom detection, care coordination, and overall care quality for this population.
For investors, the LinkedIn content suggests that Resilience Care is aligning itself with emerging standards in geriatric oncology and data‑driven care models. If the company’s offerings are tied to remote monitoring or ePRO solutions, this focus could position it to benefit from rising demand for technologies that address aging cancer demographics and evidence‑based care pathways.
The emphasis on clinical trial representation and structured follow‑up may also point to potential collaborations with research institutions, regulators, or healthcare providers active in oncology. Such positioning could expand Resilience Care’s addressable market and strengthen its credibility in specialized cancer care niches, though the post does not provide specific commercial or financial details.